ASAP Welcomes AstraZeneca As Global Member

Share Article

Pharmaceutical Industry Leader to Collaborate with Leading Professional Association Dedicated to Alliance Management

The Association of Strategic Alliance Professionals (ASAP) today announced that AstraZeneca has become a Global Member of the world’s leading professional association dedicated to the practice of alliance management. AstraZeneca will utilize ASAP’s certification and training tools and leverage the association’s network of the world’s leading alliance management executives and organizations to ensure its alliance personnel are implementing the discipline’s latest techniques.

As a Global Member, AstraZeneca will have the opportunity to serve in leadership positions within ASAP and receive discounts to workshops and events, including Chief Alliance Officer Forums and the Global Alliance Summit. The company will also have the right to allocate a percentage of its roster for employees of its partners, ensuring that both parties are implementing best practices.

“Alliances have been woven into the fabric of the pharmaceutical industry for many years, which is why many leading companies have joined the ASAP community to help each other make sure their alliance management practices stay sharp,” said Art Canter, president and CEO of ASAP. “We look forward to providing our knowledge base to bolster AstraZeneca’s alliance management program, while mutually benefiting from AstraZeneca’s experience and long track record of alliance management success.”

AstraZeneca’s in-house Alliance Management Center of Excellence plays a key role in supporting the company in delivering optimum value from its partnerships. Its responsibilities include monitoring alliance management processes and capabilities to ensure the company is adopting the best practice while nurturing a culture of effective alliance management behaviors across the organization. AstraZeneca will utilize its ASAP Global Membership as one resource to further support these goals.

Nick Dunscombe, global leader of alliance management at AstraZeneca, said, “Our aspiration is to be perceived as the partner of choice and we believe one of the key differentiators which could support this is having an industry-leading Alliance Management function. By leveraging the vast domain of alliance management expertise that comes with ASAP Global Membership, we can better achieve the company goals.”
AstraZeneca joins several leading biopharmaceutical companies as ASAP Global Members, including Eli Lilly, Quintiles, Abbott, Novartis and Sanofi.

About AstraZeneca
AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit:

About ASAP
The Association of Strategic Alliance Professionals (ASAP) is the only professional association dedicated to elevating and promoting the profession of alliance management. Founded in 1998, the organization provides professional development, networking and resources for cultivating the skills and toolsets needed to manage successful business partnerships. Active global members include Abbott Laboratories, CA, Capgemini, Cisco, Dell, Eli Lilly and Company, IBM, Juniper Networks, Microsoft, Novartis, Quintiles, USAA, Sanofi, SAS, Schneider Electric, Symantec and Xerox. A complete list of global members is available at

ASAP Media, the media and publishing arm of the Association of Strategic Alliance Professionals, is an alliance of ASAP and JW DeWitt Business Communications. For more information, visit and


Share article on social media or email:

View article via:

Pdf Print

Contact Author

JW DeWitt Business Communications
(415) 572-4408
Email >
Visit website